Clinical Trial Update: A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer [Phase 1]

View source ↗

Summary

A Phase I study evaluating a combination of nab-paclitaxel (Abraxane) with cisplatin, 5-fluorouracil, and chemoradiotherapy in patients with advanced head and n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Abraxane (paclitaxel albumin-bound)
• CISPLATIN (cisplatin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Head and Neck Cancer | Phase 1 | Status: COMPLETED